DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas will participate on a panel entitled "Invest Globally: A Framework for Building Great Companies" at the CED's Globalization 2008 Conference
News | 02. 14. 2008
